How to Plan for the Obesity Drug Revolution

Analysis February 27, 2024 at 01:37 PM
Share & Print

What You Need To Know

  • Life insurers are starting to think about what Wegovy, Saxenda and successors could do for your clients.
  • Fewer obesity-related health complications could mean many clients will have different long-term financial planning needs.
  • The drugs still come with high costs, unpleasant side effects, and the possibility that they will work better for some people than others in the long term.
NOT FOR REPRINT

© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Related Stories

Resource Center